Grove Bank & Trust’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10
Closed -$1.02K 868
2025
Q4
$1.02K Hold
10
﹤0.01% 822
2025
Q3
$547 Hold
10
﹤0.01% 817
2025
Q2
$531 Hold
10
﹤0.01% 834
2025
Q1
$433 Hold
10
﹤0.01% 830
2024
Q4
$562 Hold
10
﹤0.01% 735
2024
Q3
$681 Hold
10
﹤0.01% 716
2024
Q2
$423 Hold
10
﹤0.01% 554
2024
Q1
$691 Hold
10
﹤0.01% 569
2023
Q4
$740 Sell
10
-96
-91% -$6.29K ﹤0.01% 583
2023
Q3
$7.23K Sell
106
-22
-17% -$1.87K ﹤0.01% 549
2023
Q2
$12K Hold
128
﹤0.01% 494
2023
Q1
$8.68K Hold
128
﹤0.01% 522
2022
Q4
$6K Buy
+128
New +$5.23K ﹤0.01% 523

Other funds holding EXAS

Grove Bank & Trust's EXAS Position: Q1 2026 in Review

Grove Bank & Trust sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10 shares — an estimated $1.02K sold.

Grove Bank & Trust first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $12K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Grove Bank & Trust reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Grove Bank & Trust sold 10 Exact Sciences shares in Q1 2026, an estimated $1.02K.
  • Grove Bank & Trust first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Grove Bank & Trust's Exact Sciences position peaked at $12K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Grove Bank & Trust's 13F filing for Q1 2026, filed 8 Apr 2026.